ACET

Adicet Bio (ACET)

About Adicet Bio (ACET)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Details

Daily high

$8.90

Daily low

$8.35

Price at open

$8.46

52 Week High

$17.44

52 Week Low

$6.01

Market cap

79.8M

Dividend yield

0.00%

Volume

96,772

Avg. volume

126,901

P/E ratio

-.46

Adicet Bio News